Similar to most CD patients, Batf2−/− mice, in which IL-23 is abnormally produced in the intestinal mucosa, spontaneously developed ileitis, suggesting that BATF2 might be required for the inhibition of IL-23-mediated CD-like intestinal inflammation. This evidence concerns the gene IL23A and Crohn ileitis.